paper-with-me

홈 › Papers

Meta-Learning Initializations for Low-Resource Drug Discovery

2020-03-12 · Cuong Q. Nguyen, Constantine Kreatsoulas, Kim M. Branson

Building in silico models to predict chemical properties and activities is a crucial step in drug discovery. However, drug discovery projects are often characterized by limited labeled data, hindering the applications of deep learning in this setting. Meanwhile advances in meta-learning have enabled state-of-the-art performances in few-shot learning benchmarks, naturally prompting the question: Can meta-learning improve deep learning performance in low-resource drug discovery projects? In this work, we assess the efficiency of the Model-Agnostic Meta-Learning (MAML) algorithm - along with its variants FO-MAML and ANIL - at learning to predict chemical properties and activities. Using the ChEMBL20 dataset to emulate low-resource settings, our benchmark shows that meta-initializations perform comparably to or outperform multi-task pre-training baselines on 16 out of 20 in-distribution tasks and on all out-of-distribution tasks, providing an average improvement in AUPRC of 7.2% and 14.9% respectively. Finally, we observe that meta-initializations consistently result in the best performing models across fine-tuning sets with $k \in \{16, 32, 64, 128, 256\}$ instances.

📄 PDF Abstract BibTeX arXiv:2003.05996

Code (1)

GSK-AI/meta-learning-qsar 공식 구현 pytorch

Tasks

Drug DiscoveryFew-Shot LearningMeta-Learning

Similar Papers 제목 키워드 기반

Meta-Learning GNN Initializations for Low-Resource Molecular Property Prediction

2020-06-12 · ICML Workshop LifelongML 2020 7 · Cuong Q. Nguyen, Constantine Kreatsoulas, Kim M. Branson

Building $\textit{in silico}$ models to predict chemical properties and activities is a crucial step in drug discovery. However, limited labeled data often hinders the application of deep learning in this setting. Meanwh…

Drug DiscoveryFew-Shot LearningMeta-LearningMolecular Property Prediction+1

Artificial Intelligence in Drug Discovery: Applications and Techniques

2021-06-09 · Jianyuan Deng, Zhibo Yang, Iwao Ojima, Dimitris Samaras 외

Artificial intelligence (AI) has been transforming the practice of drug discovery in the past decade. Various AI techniques have been used in a wide range of applications, such as virtual screening and drug design. In th…

Drug DesignDrug DiscoveryMolecular Property PredictionProperty Prediction+1

COMO: A Pipeline for Multi-Omics Data Integration in Metabolic Modeling and Drug Discovery

2020-11-04 · Brandt Bessell, Josh Loecker, Zhongyuan Zhao, Sara Sadat Aghamiri 외

Identifying potential drug targets using metabolic modeling requires integrating multiple modeling methods and heterogenous biological datasets, which can be challenging without sophisticated tools. We developed COMO, a …

Data IntegrationDrug Discovery

SMILES-Mamba: Chemical Mamba Foundation Models for Drug ADMET Prediction

2024-08-11 · Bohao Xu, Yingzhou Lu, Chenhao Li, Ling Yue 외

In drug discovery, predicting the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of small-molecule drugs is critical for ensuring safety and efficacy. However, the process of accurately …

Drug DiscoveryMambaMolecular Property PredictionProperty Prediction+1

The Clinical Trials Puzzle: How Network Effects Limit Drug Discovery

2023-01-25 · Kishore Vasan, Deisy Gysi, Albert-Laszlo Barabasi

The depth of knowledge offered by post-genomic medicine has carried the promise of new drugs, and cures for multiple diseases. To explore the degree to which this capability has materialized, we extract meta-data from 35…

Drug Discovery